$0.06
10.37% day before yesterday
Nasdaq, Jul 25, 10:17 pm CET
ISIN
US67022C1062
Symbol
NCNA

NuCana plc Sponsored ADR Stock price

$0.06
-0.03 32.66% 1M
-1.07 94.73% 6M
-1.13 94.99% YTD
-3.54 98.34% 1Y
-55.57 99.89% 3Y
-137.44 99.96% 5Y
-403.69 99.99% 10Y
-403.69 99.99% 20Y
Nasdaq, Closing price Fri, Jul 25 2025
+0.01 10.37%
ISIN
US67022C1062
Symbol
NCNA
Industry

Key metrics

Basic
Market capitalization
$20.6m
Enterprise Value
$15.5m
Net debt
positive
Cash
$5.3m
Shares outstanding
151.9m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
negative
P/B
3.7
Financial Health
Equity Ratio
40.3%
Return on Equity
-319.1%
ROCE
-405.2%
ROIC
-286.6%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-22.9m | -
EBIT
$-23.5m | $-38.0m
Net Income
$-19.7m | $-1.5b
Free Cash Flow
$-22.3m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
45.1% | -
EBIT
44.6% | -23.1%
Net Income
45.0% | -5,848.2%
Free Cash Flow
25.9%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-0.1
FCF per Share
$-0.1
Short interest
7.9%
Employees
21
Rev per Employee
$0.0
Show more

Is NuCana plc Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

NuCana plc Sponsored ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a NuCana plc Sponsored ADR forecast:

6x Buy
75%
2x Hold
25%

Analyst Opinions

8 Analysts have issued a NuCana plc Sponsored ADR forecast:

Buy
75%
Hold
25%

Financial data from NuCana plc Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 6.01 6.01
25% 25%
-
- Research and Development Expense 17 17
48% 48%
-
-23 -23
45% 45%
-
- Depreciation and Amortization 0.61 0.61
20% 20%
-
EBIT (Operating Income) EBIT -23 -23
45% 45%
-
Net Profit -20 -20
45% 45%
-

In millions USD.

Don't miss a Thing! We will send you all news about NuCana plc Sponsored ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

NuCana plc Sponsored ADR Stock News

Neutral
GlobeNewsWire
6 days ago
EDINBURGH, United Kingdom, July 21, 2025 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) (“NuCana” or the “Company”) announces it has successfully canceled all remaining Series A Warrants, issued in the registered direct offering on May 7, 2025, pursuant to its letter agreements with the holders of the Series A Warrants, having raised the full amount of capital required to complete the cancellati...
Neutral
GlobeNewsWire
16 days ago
EDINBURGH, United Kingdom, July 11, 2025 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) (“NuCana” or the “Company”) announced plans to change the ratio of its American Depository Shares (“ADSs”) to its ordinary shares from one (1) ADS, representing twenty-five (25) ordinary shares, to one (1) ADS representing five thousand (5,000) ordinary shares (the "ADS Ratio"). The change in the ADS Ratio is...
Neutral
GlobeNewsWire
about 2 months ago
Initiation of Expansion Study of NUC-7738 in Combination with Pembrolizumab for Patients with PD-1 Inhibitor-Resistant Melanoma
More NuCana plc Sponsored ADR News

Company Profile

NuCana Plc engages in the development of technology platform for the treatment of patients with cancer. Its Protide technology consists of acelarin, NUC-3373 and NUC-7738. The company was founded by Hugh S. Griffith and Christopher B. Wood on January 28, 1997 and is headquartered in Edinburgh, the United Kingdom.

Head office United Kingdom
CEO Hugh Griffith
Employees 21
Founded 1997
Website www.nucana.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today